Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients-Reference-Cited by-同舟云学术

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients

Published:2022-01-06 Issue:1 Volume:139 Page:134-137
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Maillard Alexis¹^ORCID,Redjoul Rabah²,Klemencie Marion³,Labussière Wallet Hélène⁴,Le Bourgeois Amandine⁵,D'Aveni Maud⁶,Huynh Anne⁷^ORCID,Berceanu Ana⁸,Marchand Tony⁹,Chantepie Sylvain¹⁰^ORCID,Botella Garcia Carmen¹¹,Loschi Michael¹²,Joris Magalie¹³,Castilla-Llorente Cristina¹⁴,Thiebaut-Bertrand Anne¹⁵,François Sylvie³,Leclerc Mathieu²,Chevallier Patrice¹⁶,Nguyen Stephanie¹

Affiliation:

1. Department of Clinical Hematology, Hôpitaux Universitaires Pitié Salpêtrière, Paris, France;

2. Department of Clinical Hematology, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Henri Mondor, Créteil, France;

3. Department of Clinical Hematology, Angers University Hospital, Angers, France;

4. Department of Clinical Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France;

5. Department of Clinical Hematology, Nantes University Hospital, Nantes, France;

6. Department of Hematology, Nancy Hospital, Nancy, France;

7. Department of Hematology, Institut Universitaire du Cancer Toulouse–Oncopole, Service de greffe de cellules souches hematopoïétiques, Toulouse, France;

8. Department of Clinical Hematology, Besançon University Hospital, Besançon, France;

9. Department of Clinical Hematology, Centre Hospitalier Universitaire (CHU) de Rennes, Rennes, France;

10. Institut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire de Caen, Caen;

11. Department of Hematology and Cell Therapy, CHU de Bordeaux, Bordeaux, France;

12. Department of Hematology, CHU de Nice, Université Cote d'Azur, Nice, France;

13. Department of Hematology, CHU Amiens, Amiens, France;

14. Institut de Cancérologie Gustave Roussy, Villejuif, France;

15. Department of Clinical Hematology, CHU de Grenoble, Grenoble, France; and

16. Department of Clinical Hematology, Nantes University Hospital, Nantes, France

Abstract

Three reports address the protection of the vulnerable population of patients with hematologic malignancies in the face of the ongoing COVID pandemic. The reports suggest that some patients who fail to mount a B-cell response to vaccine may nevertheless have protective T cell responses. As a group, these reports suggest that patients should continue to be immunized with additional doses to attempt to improve immune response but that they need to maintain the precautions recommended for the unvaccinated.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/139/1/134/1857720/bloodbld2021014232.pdf

Reference19 articles.

1. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey;Ljungman;Leukemia.,2021

2. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med.,2021

3. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med.,2020

4. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients;Kamar;N Engl J Med.,2021

5. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA.,2021

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study;Vaccine;2023-11

2. Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS‐CoV‐2 Omicron in patients with haematological malignancies: A national prospective cohort study;British Journal of Haematology;2023-10-03

3. Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis;Vaccines;2023-09-28

4. COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy;Transplant Infectious Disease;2023-09-28

5. SARS-CoV-2 Vaccine Non-response among Hematopoietic Stem Cell Transplant Patients: A Systematic Review and Meta-analysis;2023-09-27